中西医结合缺血脑保护药物干预策略的阐释与发挥

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	hakimam.ischemicpenumbra-thetherapeuticwindow[j].neurology,1998,51(suppl3)：44－46.
[2]	jarskoglf,gilmorejh.developmentalexpressionofbcl-2proteininhumancortex[j].brainresdevbrainres,2000,119(2):225－230.
[3]	fisherm,schaebitzw.anoverviewofacutestroketherapy：past,present,andfuture[j].archinternmed,2000,160(21)：3196－3206.
[4]	legosjj,baronefc.updateonpharmacologicalstrategiesforstroke：prevention,acuteinterventionandregeneration[j].curropininvestigdrugs,2003,4(7)：847－858.
[5]	ontenienteb,rasikas,benchouaa,etal.molecularpathwaysincerebralischemia：cuestonoveltherapeuticstrategies[j].molneurobiol,2003,27(1)：33－72.
[6]	ovbiageleb,kidwellcs,starkmans,etal.neuroprotectiveagentsforthetreatmentofacuteischemicstroke[j].currneurolneuroscirep,2003,3(1)：9－20.
[7]	fisherm,ratanr.newperspectivesondevelopingacutestroketherapy[j].annneurol,2003,53(1)：10－20.
[8]	沈思钰,于振华,傅晓东,等.中医药干预缺血性中风的治疗时间窗[j].云南中医学院学报,2003,26(4)：14－16.
[9]	shensy,caidf,chenwh,etal.theeffectofxingnaojingonhippocampaln-methyl-d-asparticacidreceptoroffocalcerebralischemiainrats[j].cjim,2003,9(1)：49－52.

Full-Text